Evidence map›Paper›PMID 42388222›Full record

ArticleJHLT open2026

Drug-coated balloon treatment of in-stent restenosis in complex severe cardiac allograft vasculopathy.

Tolulope Popoola, Madhan Shanmugasundaram, Elizabeth Juneman, Deepak Acharya

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tolulope PopoolaDepartment of Internal Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Madhan ShanmugasundaramDivision of Cardiovascular Diseases, Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona.
Elizabeth JunemanDivision of Cardiovascular Diseases, Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona.
Deepak AcharyaDivision of Cardiovascular Diseases, Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac allograft vasculopathy (CAV) is a leading cause of late graft failure with limited revascularization options and high rates of in-stent restenosis (ISR). This report details a 33-year-old heart transplant recipient with progressive CAV that underwent multiple prior revascularizations, including drug-eluting stents and coronary artery bypass grafting. He developed ISR of the right coronary artery stent, treated with paclitaxel drug-coated balloon (DCB) without further stenting. Follow-up at 3 and 9 months showed patent vessels without recurrent restenosis and preserved graft function. DCB may be a viable option for ISR in advanced CAV when additional stenting is undesirable. Larger studies are needed to define its long-term role.

Indexed as

cardiac allograft vasculopathydrug-coated balloonheart transplantationin-stent restenosis

Identifiers

PMID42388222
PMCPMC13321250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.